For instance, K-ras mutations are detected in 20–30% of adenocarcinomas and inactivation of tumor suppressor genes, such as p53, p16INK4a, and Rb are frequently observed as well [2], [3], [4], [5]. This evidence concerns the gene KRAS and adenocarcinoma.